These data highly support our experimental data, where we have concluded in the previous section that less functioning of BRIP1, due to compromised BRCA1 activity, leads to the severity with overexpression of proliferative, stemness, angiogenic, and metastatic markers, supporting the aggressive nature of cancer progression. This evidence concerns the gene BRCA1 and cancer.